One previous network meta-analysis compared the efficacy of oral antidiabetic drugs on cardiovascular events and mortality42; however, the results did not reveal differences in the effects of DPP-4 inhibitors and other antidiabetic agents or a placebo on MI in patients with T2DM. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.